Go to content
Go to main menu
Go to additional information
The Institute for Medical Immunology (IMI) is a research Institute of the ULB supported by the Pharmaceutical company GlaxoSmithKline Biologicals and the Walloon Region with the objective to run research activities in the field of vaccines and allografts, to be a training centre and to exploit research results thanks to a strategic agreement with GSK Bio.
Research